147
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Correlation Between Triglyceride-Glucose Index and SARS-CoV-2 RNA Re-Positive in Discharged COVID-19 Patients

, , , , &
Pages 3815-3828 | Published online: 17 Jul 2022

References

  • Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382:1199–1207. doi:10.1056/NEJMoa2001316
  • Worldometer. COVID-19 coronavirus pandemic. Available online at: https://www.worldometers.info/coronavirus. Accessed December 1, 2021.
  • Chen D, Xu W, Lei Z, et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report. Int J Infect Dis. 2020;93:297–299. doi:10.1016/j.ijid.2020.03.003
  • Li Y, Hu Y, Yu Y, et al. Positive result of Sars‐Cov‐2 in faeces and sputum from discharged patients with COVID‐19 in Yiwu, China. J Med Virol. 2020;92(10):1938–1947. doi:10.1002/jmv.25905
  • Deng W, Guang T-W, Yang M, et al. Positive results for patients with COVID-19 discharged form hospital in Chongqing, China. BMC Infect Dis. 2020;20(1):1–6. doi:10.1186/s12879-020-05151-y
  • Xiao AT, Tong YX, Zhang SJ. False‐negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: rather than recurrence. J Med Virol. 2020;92:1755–1756. doi:10.1002/jmv.25855
  • Yuan J, Kou S, Liang Y, Zeng J, Pan Y, Liu L. Polymerase chain reaction assays reverted to positive in 25 discharged patients with COVID-19. Clin Infect Dis. 2020. 71(16):2230–2232. doi:10.1093/cid/ciaa398
  • Li C, Ji F, Wang L, et al. Asymptomatic and human-to-human transmission of SARS-CoV-2 in a 2-family cluster, Xuzhou, China. Emerg Infect Dis. 2020;26(7):1626-1628. doi:10.3201/eid2607.200718
  • Kenyon C. The prominence of asymptomatic superspreaders in transmission mean universal face masking should be part of COVID-19 de-escalation strategies. Int J Infect Dis. 2020;97:21–22. doi:10.1016/j.ijid.2020.05.102
  • Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. doi:10.1089/met.2008.0034
  • Vasques ACJ, Novaes FS, de Oliveira MD, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100. doi:10.1016/j.diabres.2011.05.030
  • Guerrero-Romero F, Villalobos-Molina R, Jiménez-Flores JR, et al. Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in young adults. Arch Med Res. 2016;47(5):382–387. doi:10.1016/j.arcmed.2016.08.012
  • Gangadharan C, Ahluwalia R, Sigamani A. Diabetes and COVID-19: role of insulin resistance as a risk factor for COVID-19 severity. World J Diabetes. 2021;12(9):1550-1562. doi:10.4239/wjd.v12.i9.1550
  • Govender N, Khaliq OP, Moodley J, et al. Insulin resistance in COVID-19 and diabetes. Prim Care Diabetes. 2021;15(4):629–634. doi:10.1016/j.pcd.2021.04.004
  • Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–3351. doi:10.1210/jc.2010-0288
  • Lu J, Peng J, Xiong Q, et al. Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR. EBioMedicine. 2020;59:102960. doi:10.1016/j.ebiom.2020.102960
  • Habibzadeh P, Sajadi MM, Emami A, et al. Rate of re-positive RT-PCR test among patients recovered from COVID-19. Biochem Med. 2020;30(3):030401. doi:10.11613/BM.2020.030401
  • Landi F, Carfì A, Benvenuto F, et al. Predictive factors for a new positive nasopharyngeal swab among patients recovered from covid-19. Am J Prev Med. 2021;60(1):13–19. doi:10.1016/j.amepre.2020.08.014
  • Zheng J, Zhou R, Chen F, et al. Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: a prospective cohort study. PLoS Negl Trop Dis. 2020;14(8):e0008648. doi:10.1371/journal.pntd.0008648
  • Tao W, Wang X, Zhang G, et al. Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. Protein Cell. 2021;12(3):230–235. doi:10.1007/s13238-020-00778-8
  • Phillips SP, Wei X, Kwong JC, et al. Duration of SARS-CoV-2 shedding: a population-based, Canadian study. PLoS One. 2021;16(6):e0252217. doi:10.1371/journal.pone.0252217
  • Roca-Ho H, Riera M, Palau V, Pascual J, Soler MJ. Characterization of ACE and ACE2 expression within different organs of the NOD mouse. Int J Mol Sci. 2017;18(3):563. doi:10.3390/ijms18030563
  • Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13(1):1–10. doi:10.1186/s12933-014-0146-3
  • Sánchez-íñigo L, Navarro-González D, Pastrana-Delgado J, Fernández-Montero A, Martínez JA. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort. J Hypertens. 2016;34(7):1257–1265. doi:10.1097/HJH.0000000000000941
  • Zhang M, Wang B, Liu Y, et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: the Rural Chinese cohort study. Cardiovasc Diabetol. 2017;16(1):1–11. doi:10.1186/s12933-017-0514-x
  • Zhang S, Du T, Zhang J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):1–8. doi:10.1186/s12944-017-0409-6
  • Sánchez‐íñigo L, Navarro‐González D, Fernández‐Montero A, Pastrana‐Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–197. doi:10.1111/eci.12583
  • Ren H, Yang Y, Wang F, et al. Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19. Cardiovasc Diabetol. 2020;19:1–8. doi:10.1186/s12933-020-01035-2
  • Šestan M, Marinović S, Kavazović I, et al. Virus-induced interferon-γ causes insulin resistance in skeletal muscle and derails glycemic control in obesity. Immunity. 2018;49(1):164177.e6. doi:10.1016/j.immuni.2018.05.005
  • Groop LC, Bonadonna RC, DelPrato S, et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest. 1989;84(1):205–213. doi:10.1172/JCI114142
  • Eketunde AO, Mellacheruvu SP, Oreoluwa P. A review of postmortem findings in patients with COVID-19. Cureus. 2020;12(7):e9438. doi:10.7759/cureus.9438
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5